期刊文献+

清热解毒方与益生菌联合治疗大鼠脓毒症 被引量:3

Qing Re Jie Du(清热解毒)Prescription Combined Probiotics in Suppressing Main Pathogens to Treat Sepsis
下载PDF
导出
摘要 目的:观察清热解毒方和益生菌联合治疗脓毒症模型大鼠的作用。方法:采用盲肠结扎穿孔法制作大鼠脓毒症模型,健康Wistar大鼠140只随机分为假手术组、脓毒症模型组、抗生素组、益生菌组、清热解毒方中药组及清热解毒方和益生菌联合治疗组,对大鼠腹水和血标本进行细菌培养鉴定及实时定量PCR检测。结果:与假手术组比较,脓毒症模型组大鼠腹水和血液中细菌检出率明显升高(P<0.05),其腹水中大肠杆菌检出率100%、金黄色葡萄球菌检出率63.6%,血液中大肠杆菌检出率94.7%、金黄色葡萄球菌检出率21.1%。与模型组比较,单纯中药组和单纯益生菌组治疗后细菌检出率和数量均有所降低(P<0.05)。与单纯用药组比较,联合治疗组上述细菌检出率和数量进一步降低(均P<0.05)。结论:脓毒症模型大鼠主要致病菌为大肠杆菌和金黄色葡萄球菌,清热解毒方和益生菌联合使用可协同抑制其主要致病菌。 Objective To detect the main pathogens in septic model of rats and find the synergism between Qing Re Jie Du(清热解毒)Prescription and Probiotics. Methods The septic model was induced by cecal li-gation and puncture. One hundred and forty healthy Wistar rats were randomly divided into six groups: control group, septic model group, antibiotic treated group, Probiotics treated group, Qing Re Jie Du (清热解毒)Pre-scription treated group and Qing Re Jie Du (清热解毒)Prescription-Probiotics group. Bacterial populations in ascites and blood were determined by bacterial culture and real time PCR. Results The bacterial numbers in model group were significantly increased compared with control data. Detection rates of Escherichia coli and Staphylococcus aureus from ascites were 100% and 63.6% respectively, meanwhile the rates of Escherichia coli and Staphylococcus aureus from blood were 94.7% and 21.1%. The detection rates and bacterial numbers in Qing Re Jie Du (清热解毒)Prescription treated group and Probiotics treated group were decreased compared with those in septic model group. Rates and numbers in Qing Re Jie Du (清热解毒)Prescription-Probiotics group were lower than those in Qing Re Jie Du(清热解毒) Prescription treated group or Probiotics treated group. Conclusion Escherichia coli and Staphylococcus aureus may be primary pathogens of septic rats in our study. Qing Re Jie Du(清热解毒)Prescription-Probiotics treated group synergizes in the treatment of sepsis.
出处 《中国中西医结合外科杂志》 CAS 2014年第2期160-163,共4页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
基金 天津市中医药管理局中医 中西医科研项目(11020)
关键词 脓毒症 清热解毒方 益生菌 致病菌 大鼠 Sepsis Qing Re Jie Du(清热解毒)prescription probiotics pathogen rat
  • 相关文献

参考文献9

  • 1刘洪斌,吴咸中,李东华,王倩,杨秀竹,薛小平,张艳萍.清热解毒方对脓毒症大鼠的治疗作用[J].中国中西医结合外科杂志,2008,14(6):580-584. 被引量:24
  • 2Rossi M, Amaretti A, and Raimondi S. Folate production by probi- otic bacteria [J]. Nutrients, 2011, 3(1): 118-134.
  • 3Williams NT. Probiotics [J]. Am J Health Syst Pharm, 2010, 67(6): 449-458.
  • 4刘大全,李东华,刘洪斌,宗春辉,高巧营.脓毒症大鼠肠道及腹水中菌群变化研究[J].中国实验诊断学,2011,15(5):812-815. 被引量:5
  • 5Buras J A, Holzmann B, Sitkovsky M. Animal models of sepsis: set- ting the stage [J]. Nat Rev Drug Discov, 2005, 4(10): 854-865.
  • 6Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of ex- perimental sepsis by cecal ligation and puncture [J]. Nat Protoc, 2009, 4(1): 31-36.
  • 7Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illnes [J]. Shock, 2007, 28(4): 384-393.
  • 8Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiot- ics-approaching a definition [J]. Am J Clin Nutr, 2001, 73(2 Sup- pl): 361-364.
  • 9Ohland CL, Maenaughton WK. Probiotie bacteria and intestinal ep- ithelial barrier funetion [J]. Am J Physiol Gastrointest Liver Physi- ol, 2010, 298(6): 807-819.

二级参考文献28

共引文献27

同被引文献41

  • 1Dellinger Rp,Levy Mm,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock : 2012 [ J ].Crit Care Med, 2013,41 (2) :580-637.
  • 2Blaser A,Poeze M,Malbrain ML,et al.Gastrointestinal symptoms during the first week of intensive care are asso- ciated with poor outcome:a prospective multi-centre study [ J ].Intensive Care Medicine, 2013,39 (5) : 899-909.
  • 3Chapman MJ,Nguyen NQ,Deane AM.Gastrointestinal dys- motility:clinical consequences and management of the criti- cally ill patient [ J ].Gastroenterol Clin North Am, 2011,40 (4) :725-739.
  • 4Eshraghian A, Eshraghian H.Interstitial ceils of Cajal:a novel hypothesis for the pathophysiology of irritable bowel syn- drome [ J ].Can J Gastroenterol, 2011,25 (5) : 277-279.
  • 5Sanger GJ.Motilin receptor neuro-pharmacology:revised un- derstanding [J ].current opinion in pharmacology, 2012, 12 (6):641-646.
  • 6Rescigno M.The intestinal epithelial barrier in the control of homestasis and immunity[J].Trends Im munol,2011,32 (6) : 256-264.
  • 7I_azaridis C, Czosnyka M.Cerebral Blood Flow, Brain Tissue Oxygen,and Metabolic Effects of Decompressive Craniec- tomy [ J ].Neurocrit Care, 2012,16(3) :478-454.
  • 8Hiraki S,Ono S,Kinoshita M,et al.Neutralization of IL-10 restores the downregulation of IL-18 receptor on natural killer ceils and interferon-',/production in septic mice,thus leading to an improved survival [ J ].Shock, 2012,37 ( 2 ) : 177-182.
  • 9Romero CR, Herzig DS, Etogo A, et al.The role of interfer- on-/in the pathogenesis of acute intra-abdominal sepsis [J ].Journal of leukocyte biology, 2010,88(4 ) : 725-735.
  • 10Ohland C L,Macnaughton W K.Probiotic bacteria and intestinal epithelial barrier function[J].Am J Physiol Gastrointest Liver Physiol,2010,298(6):807-819.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部